TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Humana ( (HUM) ).
Humana Inc. announced that its senior management will meet with investors and analysts throughout December 2025 to reaffirm its earnings guidance for the year. The company projects approximately $12.26 in diluted earnings per share and $17.00 in adjusted earnings per share for FY 2025. This guidance aligns with previous announcements and highlights the company’s focus on providing a comprehensive view of its core operating performance through both GAAP and non-GAAP measures. The reaffirmation of earnings guidance suggests stability in Humana’s financial outlook and operational strategies, potentially impacting stakeholder confidence and market positioning.
The most recent analyst rating on (HUM) stock is a Hold with a $234.00 price target. To see the full list of analyst forecasts on Humana stock, see the HUM Stock Forecast page.
Spark’s Take on HUM Stock
According to Spark, TipRanks’ AI Analyst, HUM is a Neutral.
Humana’s overall stock score reflects a mixed outlook. The company’s strong earnings call and strategic initiatives are positive, but technical indicators and valuation suggest caution. Financial performance shows stable revenue growth but highlights challenges in profitability and cash flow management.
To see Spark’s full report on HUM stock, click here.
More about Humana
Humana Inc. operates in the healthcare industry, primarily providing health insurance services. The company focuses on offering a range of health plans and services to individuals, families, and businesses, with a market emphasis on managed care and health maintenance organizations.
Average Trading Volume: 1,901,721
Technical Sentiment Signal: Strong Sell
Current Market Cap: $29.56B
For an in-depth examination of HUM stock, go to TipRanks’ Overview page.